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The metabolic and immune adaptation to extracellular signals allows macrophages 
to	carry	out	specialized	functions	involved	in	immune	protection	and	tissue	homeo-
stasis.	Nuclear	 factor	 erythroid	 2-related	 factor	 2	 (NRF2)	 is	 a	 transcription	 factor	
that	coordinates	cell	redox	and	metabolic	responses	to	stressors.	However,	the	in-
dividual	and	concomitant	activation	of	NRF2	and	inflammatory	pathways	have	been	
poorly investigated in isolated macrophages. We here took advantage of reporter 
mice	for	the	transcriptional	activities	of	NRF2	and	nuclear	factor-kB	(NFκB),	a	key	















consequences for the pharmacological treatment of diseases that are associated with 
unopposed inflammatory responses.
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1  | INTRODUC TION
Tissue-resident	 macrophages,	 such	 as	 those	 populating	 the	 peri-
toneal	cavity	or	brain,	derive	from	progenitor	cells	 that	self-renew	
and differentiate locally under the influence of microenvironmental 
cues.1,2	These	immune	cells	are	extremely	reactive	and,	in	response	
to	a	broad	variety	of	physiological	and	pathological	stimuli,	activate	
a spectrum of different transcriptional programs and functional 
responses,	 simplistically	 included	within	 two	 extreme	 phenotypes	
defined	 as	 “classical”,	 or	M1,	 and	 “alternative”,	 or	M2,	 activation.3 







In order to meet the energy demand required for functional spe-
cialization,	M1	macrophages	are	characterized	by	a	metabolic	shift	to-
ward	aerobic	glycolysis,	 carbon	 flux	 through	 the	pentose	phosphate	
pathway	 (PPP),	 and	 fatty	 acid	 synthesis,	 with	 truncated	 TCA	 cycle,	






expression is highly induced in inflammatory macrophages.5-8	 Thus,	
elucidating the interconnections between immune and metabolic re-
sponses in macrophages might help in understanding the physiology 
of cell adaptation and the pathological consequences of unopposed or 
elusive inflammatory responses.9
Nuclear	 factor	 erythroid	 2-related	 factor	 2	 (NRF2)	 is	 a	 tran-




KEAP1-NRF2	 binding	 and	 allows	NRF2	 to	migrate	 to	 the	 nucleus	
and	 bind	 antioxidant	 responsive	 elements	 (AREs)	 within	 target	
genes,	 following	 heterodimerization	with	MAF	 proteins.10 The re-
sulting transcriptional program allows detoxification from the initial 
chemical stressor and the activation of cytoprotective antioxidative 
reactions.	 More	 recent	 studies,	 using	 animal	 models	 of	 dysregu-
lated inflammation which also carry genetic manipulations of the 
KEAP1-NRF2	complex,	demonstrated	 that	NRF2	 is	also	necessary	
for	mounting	an	appropriate	innate	immune	response,	as	its	activity	
has been associated with a reduced production of pro-inflammatory 
cytokines during inflammation.11-15	 In	 general,	 the	metabolic	 shift	
that accompanies cell adaption to stressors has been associated with 
NRF2-mediated	generation	of	anabolic	precursors	and	NADPH.16,17 
However,	the	specific	metabolic	response	of	macrophages	and	their	
adaptation	 to	 the	 simultaneous	 activation	of	NRF2	and	 inflamma-




deciphering the complexity of macrophage immune-metabolic net-
work under multiple activatory stimuli and through the use of a more 
reliable experimental model of tissue-resident macrophages.
The aim of the present study is thus to use primary cultures of 
peritoneal macrophages and evaluate their immune and metabolic 
responses	to	the	NRF2-activator,	tBHQ,	and	the	bacterial	wall	com-
ponent,	lipopolysaccharide	(LPS).	Exploiting	the	availability	of	NRF2	











kept in temperature-controlled facilities on a 12-hour light and 
dark	 cycle.	Animals	were	housed	 in	 the	animal	 care	 facility	of	 the	
Department of Pharmacological and Biomolecular Sciences at the 
University	of	Milan.	Animal	investigation	has	been	conducted	in	ac-
cordance with the ethical standards and according to the Declaration 









2.2 | Primary cultures of peritoneal macrophages
Peritoneal cells were recovered by peritoneal lavage as previously 
described.20	Briefly,	5	mL	of	prechilled	0.9%	NaCl	was	injected	into	
the	peritoneal	cavity	using	a	21	G	needle,	and	cell	suspension	was	
recovered	 and	 centrifuged;	 following	 incubation	with	ACK	 solu-
tion	(0.15-mol/L	NH4Cl,	1-mmol/L	KHCO3,	and	0.1-mmol/L	EDTA;	
pH	 7.3)	 for	 5	minutes	 at	 4°C,	 cells	 were	 seeded	 at	 the	 concen-
tration of 1 × 106	 cells/mL	 in	RPMI	 (Life	Technology-Invitrogen)	
supplemented	 with	 10%	 endotoxin-free	 FBS,	 1%	 penicillin/
streptomycin,	and	1%	Na-pyruvate.	After	45	minutes	and	several	
washes	 in	PBS,	the	medium	was	replaced	with	RPMI	w/o	phenol	





in each experiment. Cell suspension was centrifuged at 1200× g,	
cell	pellets	were	re-suspended	in	TRIzol	reagent	(Life	Technology-
Invitrogen),	and	stored	at	−80°C	for	RNA,	while	supernatant	was	
stored	 for	 ELISA	 analyses.	 tBHQ	 induces	 a	 strong	 antioxidant	
response	 through	mitochondrial	 oxidative	 stress	 and	NRF2	 acti-
vation,21 without inducing cell toxicity in our experimental condi-
tions	(data	not	shown).
2.3 | RNA preparation and expression analyses




murine	 leukemia	 virus	 reverse	 transcriptase	 (Promega)	 in	 a	 final	






in	triplicate	on	a	96-well	plate	using	QuantStudio® 3 real-time PCR 
system	 (Applied	 Biosystems)	 with	 the	 following	 thermal	 profile:	
2	minutes	at	95°C;	40	cycles,	15	seconds	at	95°C,	and	1	minutes	




Cells	 were	 lysed	 with	 Luciferase	 Cell	 Culture	 Lysis	 Reagent	
(Promega)	 and	 the	 luciferase	 assay	 was	 carried	 out	 in	 luciferase	
assay	buffer	(470-μm	luciferin,	20-mm	Tricine,	0.1-mm	EDTA,	1.07-
mm	(MgCO3)4·Mg(OH)2	×	5H2O;	2.67-mm	MgSO4	×	7H2O	in	H2O,	
pH	7.8,	with	 33.3-mm	DTT	 and	 530-μm	ATP),	 using	 20	μL	 of	 cell	
lysate and 100 μL	 of	 luciferase	 assay	 buffer.	 Luminescence	 emis-
sion	was	measured	with	a	Veritas	 luminometer	 (Promega).	Protein	




Culture medium from peritoneal macrophages treated with differ-
ent	combinations	of	tBHQ	and	LPS	was	assayed	for	IL-1β,	IL-6,	and	







significance of P < .05 was accepted. Statistical analysis was per-
formed	using	GraphPad	Prism	software,	version	8.
3  | RESULTS
3.1 | Reciprocal interference between NRF2 and 
NFκB transcriptional activities in macrophages
Although	 cell	 metabolism	 and	 immune	 functions	 are	 strictly	 inter-
connected	in	macrophage	physiology,	the	effects	of	the	concomitant	
activation	 of	 inflammatory	 and	 NRF2-activating	 signals	 in	 the	 im-
munometabolic adaptation of resident macrophages are still poorly 
defined.	We	 first	 took	 advantage	of	 the	ARE-luc2	 reporter	mice,	 a	
transgenic	strain	engineered	to	express	enzyme	luciferase	under	the	




and protein extracts were prepared after 6 and 16 hours to measure 
bioluminescence	emission.	As	expected,	treatment	with	tBHQ	results	













ing	NFκB-responsive elements.19	NFκB-luc2 peritoneal macrophages 
were	treated	as	reported	above.	As	expected,	LPS	induces	luciferase	
activity	 in	a	 time-dependent	manner,	with	10-	and	3-fold	 inductions	
observed	after	6	and	16	hours,	respectively	(see	Figure	1B).	Both	short	
and	prolonged	NFκB-mediated transcriptional effects are reduced with 
the tBHQ +	LPS	treatment;	interestingly,	tBHQ	alone	also	provides	in-
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3.2 | Validation of NRF2 target genes in 
macrophages
By coupling an antioxidant activity with a shift in energetic metabo-
lism,	 the	 NRF2-mediated	 response	 is	 a	 key	 system	 in	 cell	 protec-
tion	against	oxidative	stress.	Diverse	NRF2	target	genes	have	been	
identified,	 depending	 on	 the	 cell	 type	 analyzed	 and	 specific	 func-
tion	required	by	NRF2	activation.	In	order	to	study	the	endogenous	
transcriptional	activity	of	NRF2	in	peritoneal	macrophages,	we	first	
performed dose- and time-dependent experiments with tBHQ and 
assessed	the	mRNA	abundance	of	candidate	target	genes.	As	shown	
in	Figure	2A,	the	mRNA	levels	coding	the	antioxidant	protein	HMOX1	
are readily increased by high concentrations of tBHQ with stronger ef-




sketolase	 (TKT),	 that	 sustain	 the	 PPP	 associated	 with	 macrophage	
polarization,	 as	 well	 as	 phosphoribosyl	 pyrophosphate	 amidotrans-





necessary to increase Tkt	expression.	Unexpectedly,	the	mRNA	levels	
encoding	PPAT	are	not	modified	by	tBHQ	at	any	concentration	used.
Altogether,	 these	 experiments	 provide	 the	 dynamics	 of	 redox	
and metabolic gene expression that is induced by the pharmacologi-
cal	activation	of	NRF2	in	peritoneal	macrophages.
3.3 | Modulation of metabolic, cell cycle, and 
inflammation-related genes by tBHQ and LPS in 
macrophages
Metabolic	 adaptation	 and	 immune	 activation	 are	 interlinked	 and	
concomitant events in macrophage immune response. The results of 
Figure	1	 lead	us	 to	predict	 that	 inflammatory	 conditions	 and	NRF2	
activation reprogram the transcriptional effects induced by each 
signaling	pathway,	causing	a	reciprocal	interference	with	macrophage	










it	 increases	the	expression	of	PPAT,	an	enzyme	 involved	 in	de	novo	
purine	biosynthesis,	 suggesting	that	LPS	may	reduce	energy	 fueling	
through	the	PPP,	as	already	reported,23	and	support	cell	proliferation,	
which	 still	 needs	 biological	 confirmation.	 Thus,	 these	 results	 show	
that	LPS	regulates	gene	expression	in	a	peritoneal	macrophage-spe-
cific manner and that it is able to modify the transcriptional effects of 
NRF2	associated	with	cell	redox	and	metabolic	adaptation.
To	analyze	the	NRF2-mediated	interference	with	the	metabolic	
effects	 of	 LPS,	we	 took	 advantage	 of	 the	 fact	 that	 the	metabolic	
F I G U R E  1   Regulation of luciferase reporter activity by oxidative 
and	inflammatory	stimuli	in	peritoneal	macrophages	from	ARE-
luc2	and	NFκB-luc2 mice. Peritoneal macrophages isolated from 
ARE-luc2	(A)	and	NFκB-luc2	(B)	reporter	animals	were	used	to	assay	










test. (df =	11;	A)	6	h:	F =	351.2,	16	h:	F =	405.3;	B)	6	h:	F =	355.6,	
16 h: F =	233.9).	(*)	P <	.05,	(**)	P <	.01,	(***)	P < .001 vs 6 h veh; (##)	
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signature	of	M1	macrophages	 is	characterized,	among	others,	by	a	
truncated	TCA	cycle.24 We thus assayed the expression of isocitrate 
dehydrogenase	 (IDH1)	and	 immune-responsive	gene	1	 (IRG1),	 two	
key	enzymes	in	macrophage	TCA	cycle	that	display	opposite	activ-
ities on citrate metabolism.7,25	 According	 to	 published	 data,9	 LPS	




reduces	 the	 inhibitory	 effects	 of	 LPS	 on	 Idh1 and potentiates its 




that	LPS	 induces	an	 immediate	and	persistent	 increase	 in	Ki67 ex-
pression and that the co-administration of tBHQ significantly re-
duces	this	effect,	in	agreement	with	what	is	shown	in	Figure	4C	on	
the	expression	of	PPAT,	the	enzyme	involved	in	de	novo	purine	bio-
synthesis. These results suggest that inflammatory stimuli sustain 
the	proliferation	of	peritoneal	macrophages,	a	response	that	is	sig-
nificantly	reduced	by	the	simultaneous	activation	of	NRF2.




we observed a significant reduction of Il-1β and Il-6	mRNA	levels	fol-
lowing tBHQ +	LPS	as	compared	to	LPS	alone,	with	a	more	persistent	
inhibition of IL-1β.	We	also	analyzed	TNFα,	since	its	expression	is	dif-
ferentially regulated by inflammatory stimuli.26	Indeed,	we	observed	




tBHQ also induces a delayed reduction of Il-1β and Il-6	mRNA	levels,	
as compared to controls. In order to obtain a biological evidence for 
the	immune	regulatory	effects	of	NRF2	on	macrophage	immune	ac-
tivation,	we	assessed	the	cytokine	protein	levels	that	were	present	
in the culture medium of macrophages treated as above. The results 
reported	in	Figure	4B	confirm	the	data	on	gene	expression	and	show	
that the combined treatment with tBHQ +	LPS	significantly	reduces	







flammatory effects through gene-specific dynamic effects.
Altogether,	these	results	show	that	the	NRF2	and	LPS	pathways,	
when	analyzed	separately,	 induce	a	macrophage-specific	subset	of	




method and expressed in relation to 3 h veh samples. Data are presented as mean values ±	SEM	(n	=	3)	of	a	single	experiment	representative	
of	at	least	two	other	independent	experiments.	Results	were	analyzed	by	two-way	ANOVA	followed	by	Dunnett's	multiple	comparisons	test	











balance	 that	 protects	 cells	 against	 chemical	 stressors.	 Recently,	
NRF2	became	an	attractive	target	for	immune-regulatory	therapies,	
as	a	negative	 role	 for	NRF2	activation	on	 inflammatory	 responses	
was	 demonstrated	 using	 in	 vivo	 LPS-mediated	 animal	 models	 or	
in	 vitro	 differentiated	 macrophages,	 also	 bearing	 Keap1 and Nrf2 
gene deletions.14,27 Our results extend this knowledge to peritoneal 
macrophages	and	show	that	the	pharmacological	activation	of	NRF2	
interferes	with	the	macrophage	response	to	LPS,	not	only	by	reduc-
ing inflammatory gene expression but also by altering the expression 
of	metabolic	enzymes	involved	in	cell	phenotypic	activation.
Initially,	 the	 anti-inflammatory	 activity	 of	 NRF2	 has	 been	 as-
cribed	to	the	upregulation	of	antioxidant	enzymes	that	are	able	to	
eliminate	ROS;	more	recently,	NRF2	has	been	shown	to	inhibit	the	
activity	 of	 the	 inflammatory	 transcription	 factor,	NFκB.12 The use 
of reporter mice in the present study allowed us to confirm this 
hypothesis,	 as	 we	 observed	 a	 persistent	 reduction	 of	 NFκB tran-
scriptional	 activity	 in	 response	 to	NRF2	 activation.	Moreover,	we	
here show that the inhibitory effects of the combined tBHQ +	LPS	
treatment,	 as	 compared	with	 those	 induced	by	 the	 two	 individual	
signals,	occur	on	both	antioxidant	and	 inflammatory	genes	shortly	
after	 their	 administration	 to	macrophages	 (see	 Figures	 3A	 and	 4),	
F I G U R E  3   Target gene expression 
following the concomitant activation 
of	NRF2	and	LPS-activating	signals	in	
peritoneal macrophages. The expression 
of	NRF2	and	LPS	target	genes	was	
evaluated in peritoneal macrophages 
treated	with	vehicle	(veh,	white	bars),	
tBHQ	(grey	bars),	LPS	(black	bars),	and	the	





Data sets for each gene were calculated 
using the 2−ΔΔCt method and expressed 
in relation to 3 h veh samples. Data are 
presented as mean values ±	SEM	(n	=	3)	
of a single experiment representative of at 
least two other independent experiments. 
Results	were	analyzed	by	one-way	
ANOVA	followed	by	Bonferroni's	multiple	
comparisons test. (df =	11;	HMOX1,	






F =	374.2,	16	h:	F =	100.6).	(*)	P <	.05,	
(**)	P <	.01,	(***)	P < .001 vs 6 h veh; (###)	
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suggesting that the downstream biochemical processes activated 
by	this	 treatment	proceed	 in	parallel	and,	probably,	 independently	
from each other. The molecular mechanisms underlying the interfer-
ence	between	NRF2	and	LPS-induced	inflammatory	mediators,	such	
as	 NFκB,	 are	 still	 not	 fully	 elucidated.	 Previous	 evidence	 showed	






It has been shown that selected metabolic molecules produced 
by	NRF2	activation	in	response	to	inflammatory	signals	are	able	to	
switch macrophages toward an anti-inflammatory phenotype.27 We 
here further extend this hypothesis and demonstrate that also the 
expression	of	metabolic	genes	 regulated	by	NRF2	or	LPS	 is	 recip-
rocally	 influenced	by	 the	 co-occurrence	of	NRF2	and	 inflammato-






that is reflected by the increase in antioxidant gene expression. On 
the	other	hand,	 the	NRF2	positive	effects	on	metabolic	genes	are	
instead	 reduced	by	 LPS,	 further	 supporting	 a	 competition	mecha-
nism	for	gene-specific	transcription	factors,	which	also	need	further	
elucidations.
F I G U R E  4  NRF2-mediated	interference	with	inflammatory	gene	expression	induced	by	LPS	in	peritoneal	macrophages.	The	expression	
of	inflammatory	genes	was	evaluated	in	peritoneal	macrophages	treated	with	vehicle	(veh,	white	bars),	tBHQ	(grey	bars),	LPS	(black	bars),	
and	the	combination	of	the	two	stimuli	(dashed	grey	bars)	for	3	or	16	h,	as	indicated.	A,	Real-time	PCR	was	used	to	analyze	the	mRNA	levels	
coding	IL-1β,	IL-6,	and	TNFα. Data sets for each gene were calculated using the 2−ΔΔCt method and expressed in relation to 3 h veh samples. 
(B)	IL-1β,	IL-6,	and	TNFα	proteins	were	analyzed	by	ELISA	immunoassay	in	the	culture	medium	of	peritoneal	macrophages	treated	as	in	(A).	
Data are presented as mean values ±	SEM	(n	=	3)	of	a	single	experiment	representative	of	at	least	two	other	independent	experiments.	
Results	were	analyzed	by	one-way	ANOVA	followed	by	Bonferroni's	multiple	comparisons	test	(in	A)	df =	11;	IL-1β,	3	h:	F =	482,	16	h:	
F =	203.7;	IL-6	3	h:	F =	332.3,	16	h:	F =	48.32;	TNFα 3 h: F =	58.70,	16	h:	F =	3367;	in	(B),	IL-1β,	df =	8,	F =	244.9;	IL-6,	3	h:	df =	8,	F =	501.4,	
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Our	 results	demonstrate	a	novel	activity	of	NRF2	 in	 inflamma-
tory macrophages that provides an antiproliferative response. The 
underlying	mechanism	 is	 still	not	clear;	however,	 the	metabolic	ef-
fects	 observed	 following	NRF2	 chemical	 activation	 are	 consistent	






operate without the need of energy to provide triose-phosphates 
that enter back glycolysis and sustain the cell metabolic switch that 
is necessary for phenotypic activation.17	Thus,	our	data	suggest	that	
NRF2	activation	in	resident	macrophages	promotes	glucose	metab-
olism through the PPP that is not followed by purine synthesis and 
cell proliferation. These data are apparently in contrast with previous 
studies	which	 showed	 a	 positive	 involvement	 of	NRF2	 in	 anabolic	
processes	leading	to	nucleotides	and	amino	acid	synthesis.	Although	
the	reasons	for	this	discrepancy	are	presently	unknown,	we	believe	
that the use of primary cultures of nonelicited peritoneal macro-
phages in the present study allows to appreciating the reactivity 
and	specialized	functions	of	this	subpopulation	of	resident	immune	
cells,	 including	 self-renewal,	 highlighting	 distinctions	 from	 macro-
phage-like cells derived from in vitro differentiation of monocytes 
or	bone	marrow	precursor	cells,	or	transformation	into	immortalized	
cell lines.
The choice of the experimental system appears also an asset 
for the study of macrophage immunometabolism that mimics the 
pathophysiologic	condition.	In	fact,	it	appears	crucial	to	understand	
the ability of macrophages to respond simultaneously to diverse 
stimuli	and	coordinate	 their	activation	with	 time,	similarly	 to	what	
is occurring in tissues when multiple and simultaneous activation 
events skew macrophage immunometabolism by altering the mo-
lecular	mechanisms	that	initiate	and	amplify	cell	polarization.22 This 
recently expanded field in immunology is gaining even more atten-
tion since causal connections are emerging between alterations of 
resident	macrophage	immunometabolism	and	pathologic	conditions,	
such as atherosclerosis and neurodegenerative diseases.30-32
Importantly,	 the	 possibility	 to	 activate	 NRF2	 by	 pharmaco-
logic agents during inflammatory conditions may have interesting 
consequences	 for	 pathologies	 characterized	 by	 unrestrained	 in-
flammatory	responses.	In	fact,	genetic	polymorphisms	of	the	Nrf2 
gene	 promoter	 region,	 that	 result	 in	 reduced	 expression	 of	 this	
transcription	 factor,	are	associated	with	an	 increased	susceptibil-
ity to inflammatory diseases in mouse models and humans.33,34 
Moreover,	endogenous	proteins,	such	as	GSK3	and	PTEN,	reduce	
NRF2	activation	 and	may	be	 involved	 in	providing	unopposed	or	
more	efficient	inflammatory	effects	through	the	inability	of	NRF2	
to counteract macrophage pro-inflammatory activation.11,35 On 
the	other	hand,	activation	of	NRF2	has	been	associated	with	sev-
eral	 diseases,	 including	 cancer.16,36 Considering the detrimental 
role played by anti-inflammatory macrophages in cancer develop-
ment,	NRF2-mediated	 interference	with	 classic	pro-inflammatory	
signaling might influence macrophage immunometabolic conver-
sion and favor the development of a tolerant phenotype that con-
curs in cancer development.
In	 summary,	 our	 study	 demonstrates	 that	 NRF2	 activation	 by	
chemical agents modifies immune and metabolic gene expression re-
ducing inflammatory and proliferative responses in peritoneal mac-
rophages.	These	effects	were	related	to	the	interference	with	NFκB 
and consequent effects on gene expression. This study strongly sup-
ports	 the	hypothesis	 that	 the	pharmacological	 regulation	of	NRF2	
changes	macrophage	phenotypic	activation,	suggesting	that	NRF2	is	
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